Bill > SF3591

This bill establishes limits on the potency of THC, the main psychoactive compound in cannabis, for various products including cannabis flower, concentrates, and topical or transdermal products, as well as similar hemp-derived products. Specifically, cannabis flower sold for adult use cannot exceed 15% total THC, while cannabis concentrates are limited to 30% total THC. Topical and transdermal cannabis and hemp products are capped at 500 milligrams of total THC per package. The bill also prohibits the sale of infused prerolls (pre-rolled cannabis joints) and certain other cannabis products that resemble candy or are marketed to children. Furthermore, it mandates that retail locations selling cannabis and hemp products must display prominent warning notices about the health risks associated with cannabis use, including potential impacts on lung health, mental health, brain development in young people, and the risks of dependence and addiction. Product packaging will also require extensive warning statements covering similar risks, as well as warnings against use during pregnancy or breastfeeding and while driving. The bill also defines "preroll" as a ready-to-smoke cannabis or hemp product.

Business and Industry

https://www.revisor.mn.gov/bills/94/2026/0/SF/3591/